Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Failure to Ensure Availability of Prescribed PRN Anti-Anxiety Medication

Playa Del Rey, California Survey Completed on 01-09-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to ensure that a prescribed PRN anti-anxiety medication, alprazolam, was available and could be administered as ordered for one resident. The resident was admitted with diagnoses including a left artificial knee joint, anxiety disorder, and depression, and was documented on the H&P as having capacity to understand and make medical decisions, with the MDS showing no cognitive impairment or change in mental status. Physician orders dated 12/17/2025 prescribed alprazolam 0.5 mg once daily PRN for anxiety manifested by episodes of inability to relax, with instructions for nurses to monitor episodes every shift, document non-drug interventions, and document effectiveness. Review of the MAR showed no alprazolam administration from 12/17/2025 through 12/29/2025, and progress notes did not show that licensed nurses contacted the pharmacy to obtain the medication during that period. The resident reported requesting alprazolam several times between 12/17/2025 and 12/27/2025 and being told by an LVN that the medication was not available; staff offered non-pharmacological interventions that were not always effective, and the resident stated that not having the medication worsened his anxiety and caused frustration and discouragement. The pharmacist stated she received the alprazolam order on 12/19/2025 but could not dispense it because it lacked the required handwritten physician signature, and that facility staff did not contact the pharmacy about the order from 12/20/2025 through 12/28/2025; a signed order was not provided until 12/29/2025, when the medication was sent. The pharmacist and RN confirmed alprazolam was not stocked in the e-kit, so no emergency supply was available. The DON and RN acknowledged that the resident did not have access to alprazolam as ordered from 12/17/2025 through 12/28/2025, that PRN medications should be in stock within two days of admission, and that the facility’s “Administering Medications” policy requiring safe and timely administration as prescribed could not be followed during that time.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙